[Asthma therapy for adults].
The goal of asthma management is to achieve control of the condition. This essentially requires environmental control measures (allergen avoidance) and patient training and education. Drug treatment comprises anti-inflammatory (corticosteroids), and bronchodilatory controller therapy (long-acting beta 2-sympathomimetics, leukotriene receptor antagonists, retarded theophylline) as well as bronchodilatory medication as required (short-acting beta 2-sympathomimetics). The number and frequency of pharmacologic therapy relates to the severity of the clinical presentation. The combination of certain controller drugs (corticosteroids with long-acting beta 2-agonists, corticosteroids with leukotriene receptor antagonists, and beta 2-agonists with leukotriene receptor antagonists) yields a synergistic therapeutic effect as well as a compliance advantage.
Kroegel
C
C
Medizinische Klinik IV, Pneumologie & Allergologie, Friedrich-Schiller-Universität Jena. claus.kroegel@med.uni-jena.de
Mock
B
B
Reissig
A
A
Hengst
U
U
Machnik
A
A
Henzgen
M
M
D000328:Adult; D018927:Anti-Asthmatic Agents / Q000627:therapeutic use; D001249:Asthma / Q000503:physiopathology / Q000628:therapy*; D001993:Bronchodilator Agents / Q000627:therapeutic use; D003131:Combined Modality Therapy; D006801:Humans
D018927:Anti-Asthmatic Agents; D001993:Bronchodilator Agents
Therapie des Asthma bronchiale im Erwachsenenalter.